FDAFDA PCAC reviews BPC-157, KPV, TB-500, MOTS-c (Jul 23) and DSIP, Semax, Epitalon (Jul 24, 2026) for 503A compounding eligibilityUPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORY12 peptides removed from FDA Category 2 (Apr 23, 2026) — removal is not approval; all remain pending PCAC reviewREGULATORYNo formal FDA reclassification published — no restricted peptide is legal to compound; 5 more peptides go to PCAC before Feb 2027RESEARCHA Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy [NCT07881783]RESEARCHStudy to Evaluate the Dose-Dependent Effect of Tirzepatide on Gastric Emptying in Adult Patients With Type 1 Diabetes [NCT07951658]RESEARCHA Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity [NCT06037252]RESEARCHA Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine [NCT07729462]RESEARCHHypersensitivity to Amylin in Post-Traumatic Headache [NCT07340775]RESEARCHEffects of Tirzepatide on Corneal Nerve Morphology and Other Ocular Parameters in Adults With Obesity [NCT07950371]NEWSSTAT+: Peptide market poised to explode with new Hims and Noom launchesRESEARCHAlleviating Carbohydrate Counting for Patients With Type-1 Diabetes Using a Closed Loop System With Weekly Subcutaneous Semaglutide [NCT06387199]RESEARCHWeight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity [NCT07423481]RESEARCHSEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years [NCT07845994]FDAFDA PCAC reviews BPC-157, KPV, TB-500, MOTS-c (Jul 23) and DSIP, Semax, Epitalon (Jul 24, 2026) for 503A compounding eligibilityUPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORY12 peptides removed from FDA Category 2 (Apr 23, 2026) — removal is not approval; all remain pending PCAC reviewREGULATORYNo formal FDA reclassification published — no restricted peptide is legal to compound; 5 more peptides go to PCAC before Feb 2027RESEARCHA Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy [NCT07881783]RESEARCHStudy to Evaluate the Dose-Dependent Effect of Tirzepatide on Gastric Emptying in Adult Patients With Type 1 Diabetes [NCT07951658]RESEARCHA Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity [NCT06037252]RESEARCHA Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine [NCT07729462]RESEARCHHypersensitivity to Amylin in Post-Traumatic Headache [NCT07340775]RESEARCHEffects of Tirzepatide on Corneal Nerve Morphology and Other Ocular Parameters in Adults With Obesity [NCT07950371]NEWSSTAT+: Peptide market poised to explode with new Hims and Noom launchesRESEARCHAlleviating Carbohydrate Counting for Patients With Type-1 Diabetes Using a Closed Loop System With Weekly Subcutaneous Semaglutide [NCT06387199]RESEARCHWeight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity [NCT07423481]RESEARCHSEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years [NCT07845994]

연구 용도로만 사용. 전체 공지 →

펩타이드 라이브러리

Oxytocin

Pitocin / OXT / The Love Hormone

Sexual Health

Oxytocin is a naturally occurring nonapeptide hormone produced in the hypothalamus and released from the posterior pituitary, often referred to as the "love hormone" for its role in social bonding, trust, and attachment. It is FDA-approved as Pitocin for the induction and augmentation of labor and for the control of postpartum hemorrhage. Beyond obstetric use, it is actively researched for applications in autism spectrum disorder, social anxiety, PTSD, and pair bonding.

작용 메커니즘

Nine-amino-acid neuropeptide hormone produced in the hypothalamus. Promotes pair bonding, social trust, empathy, and orgasm. Stimulates uterine contractions and milk letdown. Modulates anxiety, stress response, and social cognition through widespread CNS receptor distribution.

연구 프로토콜

연구 용도만 사용 가능. 의학적 조언은 아닙니다.

Intranasal research protocols use 20-40 IU per dose. IV protocols (obstetric) use 10-40 units in saline infusion. Sublingual protocols under investigation. Intranasal effects on social behavior studied at single doses.

연구 노트

Clinical Research Status

Oxytocin has decades of FDA-approved use as Pitocin for labor induction, augmentation of labor, and postpartum hemorrhage control. Intranasal oxytocin (Syntocinon) is available in some countries and is extensively studied in psychiatric and behavioral research. Clinical trials for autism spectrum disorder, social anxiety, and PTSD have produced mixed but promising results, with ongoing research refining optimal dosing and target populations.

Key Published Findings

Research demonstrates oxytocin's role in enhancing trust, empathy, and social memory in healthy volunteers and clinical populations. Intranasal administration at 24-40 IU has been shown to cross the blood-brain barrier and modulate amygdala reactivity and social cognition in fMRI studies. In autism research, meta-analyses show modest improvements in social recognition and eye contact, though effect sizes vary considerably across studies and populations.

Safety Profile

Intravenous oxytocin for labor carries risks of uterine hyperstimulation, fetal distress, and rare water intoxication due to antidiuretic effects at high doses. Intranasal formulations used in research have a favorable safety profile with minimal reported adverse effects (occasional nasal irritation, mild headache). Cardiovascular effects are minimal at physiological doses, though rapid IV bolus can cause transient hypotension and reflex tachycardia.

Comparison to Related Compounds

Oxytocin is structurally similar to vasopressin (differing by only two amino acids) but has distinct receptor selectivity and physiological effects. Synthetic analogs like carbetocin have been developed with longer half-lives for obstetric use, reducing the need for continuous infusion. Unlike pharmaceutical anxiolytics, oxytocin's pro-social effects appear specific to social cognition rather than generalized anxiety reduction.

Community Observations

Intranasal oxytocin has generated significant interest in biohacking and optimization communities for its reported pro-social and anxiolytic effects in social situations. Users typically report subtle effects on social warmth and connection rather than dramatic pharmacological responses. Researchers caution that oxytocin's effects are highly context-dependent, with some studies showing increased in-group favoritism or defensive aggression in competitive contexts.

반감기

~3-5 minutes (IV); ~30 min (intranasal)

재조성

Sterile saline (injection) or pre-mixed nasal spray

보관

건조한 상태

Refrigerate 2-8C.

재조성된 상태

Refrigerate 2-8C. Use within 28 days for nasal formulations.

미국 법적 상태

FDA-approved (Rx, obstetric use)

또는 알려진 이름으로

PitocinOXTThe Love Hormone

자주 묻는 질문

Oxytocin란 무엇인가요?

Oxytocin is a naturally occurring nonapeptide hormone produced in the hypothalamus and released from the posterior pituitary, often referred to as the "love hormone" for its role in social bonding, trust, and attachment. It is FDA-approved as Pitocin for the induction and augmentation of labor and for the control of postpartum hemorrhage. Beyond obstetric use, it is actively researched for applications in autism spectrum disorder, social anxiety, PTSD, and pair bonding.

Oxytocin는 어떻게 작용하나요?

Nine-amino-acid neuropeptide hormone produced in the hypothalamus. Promotes pair bonding, social trust, empathy, and orgasm. Stimulates uterine contractions and milk letdown. Modulates anxiety, stress response, and social cognition through widespread CNS receptor distribution.

Oxytocin의 미국 규제 현황은 어떤가요?

FDA-approved (Rx, obstetric use)

Oxytocin의 반감기는 얼마인가요?

~3-5 minutes (IV); ~30 min (intranasal)

Oxytocin의 다른 이름은 무엇인가요?

Pitocin, OXT, The Love Hormone

Peptide Contacts는 정보 제공을 위해 연구 기반 요약을 제공합니다. 우리는 공급업체 문서를 호스팅, 배포하거나 지지하지 않습니다. 모든 테스트 보고서, GMP 인증서 및 공급업체 통신은 구매자는 직접 요청하고 확인해야 합니다. 이 플랫폼에서 제공되는 어떠한 정보도 법적, 의학적 또는 전문적인 조언을 대체하지 않습니다. 사용자는 모든 관련 지역법, 주법 및 연방법에 부합하기 위해 공급업체 자격 증명을 검증하고 구매하기 전에 준수해야 합니다. 이 플랫폼의 사용은 이러한 책임을 완전히 지닌 것으로 간주됩니다.

전체 공지사항 읽기